Literature DB >> 7034544

Non-Hodgkin's lymphomas. analysis of 109 Japanese cases with the use of LSGJ classification.

M Shimizu, M Miura, M Kitahara, I Katayama.   

Abstract

Recently the Lymphoma Study Group of Japan (LSGJ) proposed a new classification of non-Hodgkin's lymphomas (NHLs), diving NHLs into the follicular group consisting of three subsets and the diffuse group, 7. Each subset of the diffuse group is further divided into B or T cell types according to immunologic markers and/or morphologic prediction. In the review of 118 malignant lymphomas, the authors studied the 109 cases of NHLs, attempting to assess the clinicopathologic utility of this classification. Morphologic criteria, enzyme histochemistry, and immunoperoxidase technique were used to ensure the accuracy of the immunologic phenotyping. The results suggest that the LSGJ classification is easily reproducible and yields a more precise clinicopathologic correlation than traditional, morphologic classifications. Consistent with similar studies in Japan, this study demonstrated a low incidence of Hodgkin's disease (7.6% of all lymphomas) and follicular lymphomas (8.3% of all NHLs) and a high incidence of T cell lymphomas (34.9% of all NHLs). The incidence (45.9%) of extranodal presentation was high. These four features seem characteristic of lymphomas in Japan.

Entities:  

Mesh:

Year:  1982        PMID: 7034544      PMCID: PMC1915975     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.

Authors:  G Frizzera; K J Gajl-Peczalska; C D Bloomfield; J H Kersey
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

2.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Malignant lymphoma, histiocytic type with sclerosis (sclerosing reticulum cell sarcoma).

Authors:  A Rosas-Uribe; H Rappaport
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

4.  Malignant lymphoma of peripheral T-lymphocyte origin: immunologic, pathologic, and clinical features in six patients.

Authors:  J A Waldron; J H Leech; A D Glick; J M Flexner; R D Collins
Journal:  Cancer       Date:  1977-10       Impact factor: 6.860

5.  A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.

Authors:  R J Lukes; C R Taylor; J W Parker; T L Lincoln; P K Pattengale; B H Tindle
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

6.  An immunohistological study of follicular lymphoma, reticulum cell sarcoma and Hodgkin's disease.

Authors:  C R Taylor
Journal:  Eur J Cancer       Date:  1976-01       Impact factor: 9.162

7.  Immunoperoxidase technics in diagnostic pathology. Report of a workshop sponsored by the National Cancer Institute.

Authors:  R A DeLellis; L A Sternberger; R B Mann; P M Banks; P K Nakane
Journal:  Am J Clin Pathol       Date:  1979-05       Impact factor: 2.493

8.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

9.  Primary extranodal lymphoma: response to treatment and factors influencing prognosis.

Authors:  R A Rudders; M E Ross; R A DeLellis
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

10.  Histochemical and immunohistochemical study of diffuse large-cell lymphomas.

Authors:  C Y Li; G Harrison
Journal:  Am J Clin Pathol       Date:  1978-11       Impact factor: 2.493

View more
  2 in total

1.  Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.

Authors:  F R Davey; K C Gatter; E Ralfkiaer; K A Pulford; G W Krissansen; D Y Mason
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

2.  A case of intestinal T-cell lymphoma with repeated episodes of perforation.

Authors:  K Yamamoto; T Shiraishi; T Ajiki; Y Imai; H Oyanagi; Y Saito
Journal:  Gastroenterol Jpn       Date:  1991-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.